We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCN
76
Waste Connections
WCN
$42.7B
$50.3M 0.32%
369,270
+92,075
+33% +$12.2M
CRL icon
77
Charles River Laboratories
CRL
$10.8B
$49.1M 0.31%
130,409
-90,296
-41% -$35.1M
MELI icon
78
Mercado Libre
MELI
$92.3B
$48.6M 0.31%
36,016
-9,104
-20% -$12.8M
TJX icon
79
TJX Companies
TJX
$173B
$47.7M 0.3%
628,064
-89,126
-12% -$6.18M
EQIX icon
80
Equinix
EQIX
$103B
$46.5M 0.3%
54,974
-2,681
-5% -$2.15M
ABBV icon
81
AbbVie
ABBV
$454B
$46.4M 0.3%
342,857
-7,930
-2% -$937K
BALL icon
82
Ball Corp
BALL
$17.2B
$46.4M 0.3%
482,144
+7,464
+2% +$690K
SLAB icon
83
Silicon Laboratories
SLAB
$7.17B
$46.4M 0.3%
224,543
-36,952
-14% -$6.8M
AVGO icon
84
Broadcom
AVGO
$1.82T
$45.9M 0.29%
689,270
+166,680
+32% +$9.37M
CMCSA icon
85
Comcast
CMCSA
$80.9B
$44.8M 0.29%
890,686
+35,257
+4% +$1.84M
BIO icon
86
Bio-Rad Laboratories Class A
BIO
$8.47B
$44.6M 0.28%
59,038
+14,195
+32% +$10.6M
BLD
87
DELISTED
TopBuild
BLD
$44.1M 0.28%
159,984
+484
+0.3% +$124K
JPM icon
88
JPMorgan Chase
JPM
$947B
$43.8M 0.28%
276,400
-21,834
-7% -$3.59M
NOW icon
89
ServiceNow
NOW
$109B
$43.8M 0.28%
337,085
+106,795
+46% +$14M
SPGI icon
90
S&P Global
SPGI
$130B
$43.1M 0.28%
91,317
-1,802
-2% -$824K
SNPS icon
91
Synopsys
SNPS
$74.5B
$43.1M 0.27%
116,903
+8,341
+8% +$2.81M
MRNA icon
92
Moderna
MRNA
$22.1B
$43M 0.27%
169,264
-39,291
-19% -$11.5M
ARVN icon
93
Arvinas
ARVN
$530M
$42.9M 0.27%
522,306
+176,712
+51% +$14.4M
VMW
94
DELISTED
VMware, Inc
VMW
$42.1M 0.27%
363,491
+172,496
+90% +$22.7M
XIFR
95
XPLR Infrastructure LP
XIFR
$1.19B
$42.1M 0.27%
498,404
+7,918
+2% +$663K
XYL icon
96
Xylem
XYL
$28.6B
$42M 0.27%
349,906
+39,295
+13% +$4.88M
DAR icon
97
Darling Ingredients
DAR
$9.62B
$41.9M 0.27%
604,390
-33,633
-5% -$2.44M
KEYS icon
98
Keysight
KEYS
$53.6B
$41.6M 0.27%
201,419
-49,043
-20% -$9.17M
ALNY icon
99
Alnylam Pharmaceuticals
ALNY
$37.2B
$40.8M 0.26%
240,571
+107,492
+81% +$20M
PLD icon
100
Prologis
PLD
$137B
$40.8M 0.26%
242,306
-15,096
-6% -$2.25M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.